In summary, our findings shed light on the mechanism of ibudilast's inhibition of Tat-induced TNFα production in microglial cells and may implicate ibudilast as a potential adjunctive therapy for the management of HAND. This evidence concerns the gene TNF and HIV-associated neurocognitive disorder.